ADMS

Adamas Pharmaceuticals, Inc.
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

117 hedge funds and large institutions have $702M invested in Adamas Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 33 increasing their positions, 33 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+22
Holders Change %
+23.16%
% of All Funds
2.66%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
39
Increased
33
Reduced
33
Closed
17
Calls
$8.83M
Puts
$2.81M
Net Calls
+$6.02M
Net Calls Change
+$6.36M
Name Holding Trade Value Shares
Change
Shares
Change %
Jane Street
126
Jane Street
New York
-$261K -12,339 Closed
FPF
127
FNY Partners Fund
New York
-$231K -10,913 Closed
NFA
128
Nationwide Fund Advisors
Ohio
-$171K -8,068 Closed
SG Americas Securities
129
SG Americas Securities
New York
-$110K -5,202 Closed
MCIA
130
Mountain Capital Investment Advisors
Colorado
-$72K -3,400 Closed
TRCT
131
Tower Research Capital (TRC)
New York
-$31K -1,483 Closed
CSS
132
Cubist Systematic Strategies
Connecticut
-$28K -1,300 Closed
HCM
133
Highlander Capital Management
New Jersey
-$21K -1,000 Closed